Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × nilotinib × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Synovitis, Pigmented Villonodular 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Giant Cell Tumor of Tendon Sheath 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 19 fludarabine 14 fludarabine phosphate 10 Vincristine 10 Methotrexate 9 venetoclax 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 blinatumomab 7 Whole-Body Irradiation 7 Dexamethasone 7 Cytarabine 7 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Mycophenolic Acid 5 Mesna 5 Doxorubicin 5 Calcium Dobesilate 5 ponatinib 4 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 calaspargase pegol 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡